The DOI matches its Crossref record; 72 of the 73 references it cites were found in a registry or an index.
Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis
Open accessAbstract
OBJECTIVE: To assess the risk of venous thromboembolism in women using hormone replacement therapy by study design, characteristics of the therapy and venous thromboembolism, and clinical background. DESIGN: Systematic review and meta-analysis. DATA SOURCES: Medline. STUDIES REVIEWED: Eight observational studies and nine randomised controlled trials. INCLUSION CRITERIA: Studies on hormone replacement therapy that reported venous thromboembolism. REVIEW MEASURES: Homogeneity between studies was analysed using chi(2) and I(2) statistics. Overall risk of venous thromboembolism was assessed from a fixed effects or random effects model. RESULTS: Meta-analysis of observational studies showed that oral oestrogen but not transdermal oestrogen increased the risk of venous thromboembolism. Compared with non-users of oestrogen, the odds ratio of first time venous thromboembolism in current users of oral oestrogen was 2.5 (95% confidence interval 1.9 to 3.4) and in current users of transdermal oestrogen was 1.2 (0.9 to 1.7). Past users of oral oestrogen had a similar risk of venous thromboembolism to never users. The risk of venous thromboembolism in women using oral oestrogen was higher in the first year of treatment (4.0, 2.9 to 5.7) compared with treatment for more than one year (2.1, 1.3 to 3.8; P<0.05). No noticeable difference in the risk of venous thromboembolism was observed between unopposed oral oestrogen (2.2, 1.6 to 3.0) and opposed oral oestrogen (2.6, 2.0 to 3.2). Results from nine randomised controlled trials confirmed the increased risk of venous thromboembolism among women using oral oestrogen (2.1, 1.4 to 3.1). The combination of oral oestrogen and thrombogenic mutations or obesity further enhanced the risk of venous thromboembolism, whereas transdermal oestrogen did not seem to confer additional risk in women at high risk of venous thromboembolism. CONCLUSION: Oral oestrogen increases the risk of venous thromboembolism, especially during the first year of treatment. Transdermal oestrogen may be safer with respect to thrombotic risk. More data are required to investigate differences in risk across the wide variety of hormone regimens, especially the different types of progestogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The increasing risk of VTE with duration of estrogen use is in contrast with menopausal hormonal therapy, where the risk is highest in the first year of use and decreases with time. [122]”
From Estrogen and thrombosis: a bench to bedside review (2020) · cites this paper as [122]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Moher, D., Pham, B., Jones, A., Cook, D. J., Jadad, A. R., Moher, M., Tugwell, P., & Klassen, T. P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01085-x · Cited by 3,560
QUANTITATIVE METHODS IN THE REVIEW OF EPIDEMIOLOGIC LITERATURE1
GREENLAND, S. (1987) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036298 · Cited by 1,644
Shape of the relapse curve and long-term abstinence among untreated smokers
Hughes, J. R., Keely, J., & Naud, S. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00540.x · Cited by 1,414
Antidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Research works printed but not linked: 2
- Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12.
- Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res 1993;2:121-45.
Cited by
Sorted by citations
ESHRE Guideline: management of women with premature ovarian insufficiency
The ESHRE Guideline Group on POI, Webber, L. J., Davies, M. C., Anderson, R. A., Bartlett, J., Braat, D. D. M., Cartwright, B., Cífková, R., Keizer‐Schrama, S. D. M., Hogervorst, E., et al. (2016) · Human Reproduction · doi:10.1093/humrep/dew027 · Cited by 1,603
Gravholt, C. H., Andersen, N. H., Conway, G. S., Dekkers, O. M., Geffner, M. E., Klein, K. O., Lin, A. E., Mauras, N., Quigley, C. A., Rubin, K., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0430 · Cited by 1,101
The 2017 hormone therapy position statement of The North American Menopause Society
The North American Menopause Society (2017) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000921 · Cited by 1,042
2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
Baber, R., Panay, N., & Fenton, A. J. (2016) · Climacteric · doi:10.3109/13697137.2015.1129166 · Cited by 968
Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline
Stuenkel, C. A., Davis, S. R., Gompel, A., Lumsden, M. A., Murad, M. H., Pinkerton, J. V., & Santen, R. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2236 · Cited by 884
Hormone Therapy and Venous Thromboembolism Among Postmenopausal Women
Canonico, M., Oger, E., Plu‐Bureau, G., Conard, J., Meyer, G., Levesque, H., Trillot, N., Barrellier, M. ‐., Wahl, D. G., Emmerich, J., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.642280 · Cited by 867
Self-citationSammaritano, L. R., Bermas, B. L., Chakravarty, E. F., Chambers, C., Clowse, M. E. B., Lockshin, M. D., Marder, W., Guyatt, G. H., Branch, D. W., Buyon, J. P., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41191 · Cited by 835
The 2012 Hormone Therapy Position Statement of The North American Menopause Society
The North American Menopause Society (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31824b970a · Cited by 787
Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement
Santen, R. J., Allred, D. C., Ardoin, S. P., Archer, D. F., Boyd, N. F., Braunstein, G. D., Burger, H., Colditz, G. A., Davis, S. R., Gambacciani, M., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2509 · Cited by 687
Epidemiology and prevention of venous thromboembolism
Lutsey, P. L., & Zakai, N. A. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00787-6 · Cited by 564
Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause
Sullivan, S. D., Sarrel, P. M., & Nelson, L. M. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.09.046 · Cited by 519
Clinical guidelines for testing for heritable thrombophilia
Baglin, T. P., Gray, E., Greaves, M., Hunt, B. J., Keeling, D. M., Machin, S. J., Mackie, I. J., Makris, M., Nokes, T., Perry, D. J., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.08022.x · Cited by 498
Hormone-replacement therapy: current thinking
Lobo, R. A. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.164 · Cited by 526
Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer
Gazzerro, P., Proto, M., Gangemi, G., Malfitano, A. M., Ciaglia, E., Pisanti, S., Santoro, A., Laezza, C., & Bifulco, M. (2011) · Pharmacological Reviews · doi:10.1124/pr.111.004994 · Cited by 465
Kujovich, J. L. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181faa0f2 · Cited by 422
Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study
Renoux, C., Dell’Aniello, S., Garbe, E., & Suissa, S. (2010) · BMJ · doi:10.1136/bmj.c2519 · Cited by 383
Estrogen and progestogen use in postmenopausal women
Utian, W. H., Archer, D. F., Bachmann, G. A., Gallagher, C., Grodstein, F., Heiman, J. R., Henderson, V. W., Hodis, H. N., Karas, R. H., Ra, L., et al. (2008) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31817b076a · Cited by 372
Maas, A. H. E. M., Rosano, G. M. C., Cífková, R., Chieffo, A., van Dijken, D., Hamoda, H., Kunadian, V., Laan, E. T. M., Lambrinoudaki, I. V., Maclaran, K., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa1044 · Cited by 382
Guidance for the evaluation and treatment of hereditary and acquired thrombophilia
Stevens, S. M., Woller, S. C., Bauer, K. A., Kasthuri, R. S., Cushman, M., Streiff, M. B., Lim, W., & Douketis, J. D. (2016) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1316-1 · Cited by 353
Long-Term Evaluation of Cross-Sex Hormone Treatment in Transsexual Persons
Wierckx, K., Mueller, S. C., Weyers, S., Caenegem, E. V., Roef, G. L., Heylens, G., & T'Sjoen, G. G. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02876.x · Cited by 338
Sammaritano, L. R., Bermas, B. L., Chakravarty, E. F., Chambers, C., Clowse, M. E. B., Lockshin, M. D., Marder, W., Guyatt, G. H., Branch, D. W., Buyon, J. P., et al. (2020) · Arthritis Care & Research · doi:10.1002/acr.24130 · Cited by 338
Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis
Douketis, J., Tosetto, A., Marcucci, M., Baglin, T., Cosmi, B., Cushman, M., Kyrle, P., Poli, D., Tait, R. C., & Iorio, A. (2011) · BMJ · doi:10.1136/bmj.d813 · Cited by 278
Barbui, C., Esposito, E., & Cipriani, A. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.081514 · Cited by 275
Golder, S., Loke, Y. K., & Bland, M. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001026 · Cited by 279
Postmenopausal Hormone Therapy and Risk of Idiopathic Venous Thromboembolism
Canonico, M., Fournier, A., Carcaillon‐Bentata, L., Olié, V., Plu‐Bureau, G., Oger, E., Mesrine, S., Boutron‐Ruault, M., Clavel‐Chapelon, F., & Scarabin, P. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.196022 · Cited by 270
Self-citationEstrogen and thrombosis: a bench to bedside review
Abou-Ismail, M. Y., Citla Sridhar, D., & Nayak, L. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.05.008 · Cited by 261
Prevention of Venous Thromboembolism in 2020 and Beyond
Nicholson, M., Chan, N., Bhagirath, V. C., & Ginsberg, J. S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082467 · Cited by 242
Cardiovascular Phenotype in Turner Syndrome—Integrating Cardiology, Genetics, and Endocrinology
Mortensen, K. H., Andersen, N. H., & Gravholt, C. H. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1059 · Cited by 221
Metabolic Syndrome and Menopause
Stefańska, A., Bergmann, K., & Sypniewska, G. (2015) · Advances in clinical chemistry · doi:10.1016/bs.acc.2015.07.001 · Cited by 222
Mechanistic View of Risk Factors for Venous Thromboembolism
Reitsma, P. H., Versteeg, H. H., & Middeldorp, S. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.242818 · Cited by 212
Cobin, R. H., & Goodman, N. F. (2017) · Endocrine Practice · doi:10.4158/ep171828.ps · Cited by 210
Menopausal hormone therapy and women’s health: An umbrella review
Zhang, G.-Q., Chen, J.-L., Luo, Y., Mathur, M. B., Anagnostis, P. G., Nurmatov, U. B., Talibov, M., Zhang, J., Hawrylowicz, C. M., Lumsden, M. A., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003731 · Cited by 228
Hormone replacement therapy and the risk of venous thromboembolism: a population-based study
Renoux, C., Dell’Aniello, S., & Suissa, S. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03839.x · Cited by 208
Oestrogen and anti-androgen therapy for transgender women
Tangpricha, V., & den Heijer, M. (2016) · The Lancet Diabetes and Endocrinology · doi:10.1016/s2213-8587(16)30319-9 · Cited by 170
Cardiovascular Disease Among Transgender Adults Receiving Hormone Therapy
Streed, C. G., Harfouch, O., Marvel, F. A., Blumenthal, R. S., Martin, S. S., & Mukherjee, M. (2017) · Annals of Internal Medicine · doi:10.7326/m17-0577 · Cited by 207
Hamoda, H., Panay, N., Pedder, H., Arya, R., & Savvas, M. (2020) · Post Reproductive Health · doi:10.1177/2053369120957514 · Cited by 192
Management of menopause: a view towards prevention
Lobo, R. A., & Gompel, A. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00269-2 · Cited by 183
Hormone Therapy in Menopause: Concepts, Controversies, and Approach to Treatment
Flores, V. A., Pal, L., & Manson, J. E. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab011 · Cited by 174
A decade of postmenopausal hormone therapy prescribing in the United States
Steinkellner, A. R., Denison, S. E., Eldridge, S. L., Lenzi, L. L., Chen, W. C., & Bowlin, S. J. (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31824bb039 · Cited by 173
Oral Contraceptives and HRT Risk of Thrombosis
Gialeraki, A. E., Valsami, S. I., Pittaras, T., Panayiotakopoulos, G. D., & Politou, M. (2017) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029616683802 · Cited by 169
An empowerment model for managing menopause
Hickey, M., LaCroix, A. Z., Doust, J. A., Mishra, G. D., Sivakami, M., Garlick, D., & Hunter, M. S. (2024) · The Lancet · doi:10.1016/s0140-6736(23)02799-x · Cited by 171
The effects of obesity on venous thromboembolism: A review
Yang, G., Staercke, C. D., & Hooper, W. C. (2012) · Open Journal of Preventive Medicine · doi:10.4236/ojpm.2012.24069 · Cited by 169
The Multiple Roles of Estrogens and the Enzyme Aromatase
Boon, W. C., Chow, J. D. Y., & Simpson, E. R. (2010) · Progress in brain research · doi:10.1016/s0079-6123(08)81012-6 · Cited by 168
The 2017 hormone therapy position statement of The North American Menopause Society
(2018) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001241 · Cited by 172
Management of premature ovarian failure
Panay, N., & Kalu, E. (2008) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2008.10.008 · Cited by 155
Metabolic Disorders in Menopause
Jeong, H. G., & Park, H. (2022) · Metabolites · doi:10.3390/metabo12100954 · Cited by 179
Roach, R. E. J., Cannegieter, S. C., & Lijfering, W. M. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12678 · Cited by 153
Pérez-López, F. R., Chedraui, P. A., Gilbert, J. J., & Pérez‐Roncero, G. R. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.06.032 · Cited by 151
Sex Difference in Risk of Second but Not of First Venous Thrombosis
Roach, R. E. J., Lijfering, W. M., Rosendaal, F. R., Cannegieter, S. C., & le Cessie, S. (2013) · Circulation · doi:10.1161/circulationaha.113.004768 · Cited by 150
Are All Estrogens Created Equal? A Review of Oral vs. Transdermal Therapy
Goodman, M. P. (2011) · Journal of Women s Health · doi:10.1089/jwh.2011.2839 · Cited by 146
HRT for women with premature ovarian insufficiency: a comprehensive review
Webber, L., Anderson, R. A., Davies, M., Janse, F., & Vermeulen, N. (2017) · Human Reproduction Open · doi:10.1093/hropen/hox007 · Cited by 141
Panay, N., Hamoda, H., Arya, R., & Savvas, M. (2013) · Menopause international · doi:10.1177/1754045313489645 · Cited by 135
Asscheman, H., T'Sjoen, G. G., Lemaire, A., Mas, M., Meriggiola, M. C., Mueller, A., Kühn, A., Dhejne, C., Morel-Journel, N., & Gooren, L. J. (2013) · Andrologia · doi:10.1111/and.12150 · Cited by 133
Hormonal Contraception and Thrombotic Risk: A Multidisciplinary Approach
Trenor, C. C., Chung, R. J., Michelson, A. D., Neufeld, E. J., Gordon, C. M., Laufer, M. R., & Emans, S. J. (2011) · PEDIATRICS · doi:10.1542/peds.2010-2221 · Cited by 134
Postmenopausal hormone therapy: risks and benefits
Rozenberg, S., Vandromme, J., & Antoine, C. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.17 · Cited by 132
Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women
Olié, V., Canonico, M., & Scarabin, P. (2010) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32833c07bc · Cited by 132
Self-citationThe 2020 Menopausal Hormone Therapy Guidelines
Lee, S. R., Cho, M. K., Cho, Y. J., Chun, S., Hong, S.-H., Hwang, K. R., Jeon, G., Joo, J. K., Kim, S. K., Lee, D. O., et al. (2020) · Journal of Menopausal Medicine · doi:10.6118/jmm.20000 · Cited by 136
Hippisley‐Cox, J., & Coupland, C. A. C. (2011) · BMJ · doi:10.1136/bmj.d4656 · Cited by 132
Update in Hormone Therapy Use in Menopause
Taylor, H. S., & Manson, J. E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0536 · Cited by 121
Hormone therapy and recurrence of venous thromboembolism among postmenopausal women
Olié, V., Plu‐Bureau, G., Conard, J., Horellou, M., Canonico, M., & Scarabin, P. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181f9f7c3 · Cited by 122
Self-citationHormonal contraceptives and venous thromboembolism: An epidemiological update
Plu‐Bureau, G., Maitrot‐Mantelet, L., Hugon‐Rodin, J., & Canonico, M. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.11.002 · Cited by 119
Self-citationWhere Are We 10 Years After the Women's Health Initiative?
Lobo, R. A. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4070 · Cited by 123
Stroke Risk Factors Unique to Women
Demel, S. L., Kittner, S. J., Ley, S. H., McDermott, M., & Rexrode, K. M. (2018) · Stroke · doi:10.1161/strokeaha.117.018415 · Cited by 124
Rovinski, D., Ramos, R. B., Fighera, T. M., Casanova, G. K., & Spritzer, P. M. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.06.014 · Cited by 120
Pathogenesis of Venous Thromboembolism: When the Cup Runneth Over
Lippi, G., & Franchini, M. (2008) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0029-1145257 · Cited by 116
Managing the menopause: An update
Roberts, H., & Hickey, M. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.01.007 · Cited by 112
Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic review
Goldštajn, M. Š., Mikuš, M., Ferrari, F. A., Bosco, M., Uccella, S., Noventa, M., Török, P., Terzic, S., Laganà, A. S., & Garzon, S. (2022) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-022-06647-5 · Cited by 111
Higgins, P., Skup, M., Mulani, P. M., Lin, J., & Chao, J. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.07.017 · Cited by 110
Laliberté, F., Dea, K., Duh, M. S., Kahler, K. H., Rolli, M., & Lefèbvre, P. (2011) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3182175e5c · Cited by 108
Prescribing menopausal hormone therapy: an evidence-based approach
Sood, R., Faubion, S. S., Kuhle, C. L., Thielen, J. M., & Shuster, L. T. (2014) · International Journal of Women s Health · doi:10.2147/ijwh.s38342 · Cited by 113
Cardiovascular Changes in Menopause
Nair, A. R., Pillai, A. J., & Nair, N. (2020) · Current Cardiology Reviews · doi:10.2174/1573403x16666201106141811 · Cited by 104
Bagot, C. N., Marsh, M. S., Whitehead, M., Sherwood, R. A., Roberts, L. N., Patel, R., & Arya, R. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03953.x · Cited by 104
T hrombotic issues in transgender medicine: A review
Shatzel, J. J., Connelly, K. J., & DeLoughery, T. G. (2016) · American Journal of Hematology · doi:10.1002/ajh.24593 · Cited by 101
Torres-Santiago, L., Mericq, V., Taboada, M., Unanue, N., Klein, K. O., Singh, R., Hossain, J., Santen, R. J., Ross, J. L., & Mauras, N. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4243 · Cited by 99
Transdermal Estradiol for Postpartum Depression: A Promising Treatment Option
Moses‐Kolko, E. L., Berga, S. L., Kalro, B. N., Sit, D. K. Y., & Wisner, K. L. (2009) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e3181b5a395 · Cited by 97
Roach, R. E. J., Lijfering, W. M., Helmerhorst, F. M., Cannegieter, S. C., Rosendaal, F. R., & Vlieg, A. V. H. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12060 · Cited by 97
Scarabin, P. (2018) · Climacteric · doi:10.1080/13697137.2018.1446931 · Cited by 96
Self-citationIs it time for a paradigm shift in drug research and development in endometriosis/adenomyosis?
Guo, S., & Groothuis, P. G. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmy020 · Cited by 93
Position statement on the hormonal management of adult transgender and gender diverse individuals
Cheung, A. S., Wynne, K., Erasmus, J., Murray, S., & Zajac, J. D. (2019) · The Medical Journal of Australia · doi:10.5694/mja2.50259 · Cited by 92
Bergendal, A., Kieler, H., Sundström, A., Hirschberg, A. L., & Kocoska-Maras, L. (2016) · Menopause · doi:10.1097/gme.0000000000000611 · Cited by 90
Different menopausal hormone regimens and risk of breast cancer
Brusselaers, N., Tamimi, R. M., Könings, P., ROSNER, B. A., Adami, H., & Lagergren, J. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy212 · Cited by 90
Hormonal contraceptives and arterial disease: An epidemiological update
Plu‐Bureau, G., Hugon‐Rodin, J., Maitrot‐Mantelet, L., & Canonico, M. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.11.003 · Cited by 89
Self-citationPremature ovarian insufficiency, early menopause, and induced menopause
Hamoda, H., & Sharma, A. (2023) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2023.101823 · Cited by 103
Haas, A. N., Rõsing, C. K., Oppermann, R. V., Albandar, J. M., & Susin, C. (2009) · Journal of Periodontology · doi:10.1902/jop.2009.090082 · Cited by 86
Hamoda, H. (2017) · Post Reproductive Health · doi:10.1177/2053369117699358 · Cited by 84
Mechanism of raloxifene-induced upregulation of glutamate transporters in rat primary astrocytes
Karki, P., Webb, A., Zerguine, A. M., Choi, J., Son, D., & Lee, E.-S. (2014) · Glia · doi:10.1002/glia.22679 · Cited by 84
Approach to the Patient with Menopausal Symptoms
Martin, K. A., & Manson, J. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1272 · Cited by 81
Kopper, N. (2008) · Drug Design Development and Therapy · doi:10.2147/dddt.s4146 · Cited by 85
Mueck, A. O. (2012) · Climacteric · doi:10.3109/13697137.2012.669624 · Cited by 83
Defreyne, J., de Bruaene, L. V., Rietzschel, E. R., Schuylenbergh, J. V., & T'Sjoen, G. G. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2018.288241 · Cited by 85
Evolution of postmenopausal hormone therapy between 2002 and 2009
Ettinger, B. B., Wang, S. M., Leslie, R. S., Patel, B. V., Boulware, M. J., Mann, M. E., & McBride, M. (2011) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31823a3e5d · Cited by 80
HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT
L’Hermite, M. (2013) · Climacteric · doi:10.3109/13697137.2013.808563 · Cited by 81
Rosendaal, F. R. (2016) · Thrombosis Journal · doi:10.1186/s12959-016-0108-y · Cited by 79
Incidence of Venous Thromboembolism in Transgender Women Receiving Oral Estradiol
Arnold, J. D., Sarkodie, E., Coleman, M. E., & Goldstein, D. A. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.09.001 · Cited by 76
Barbui, C., Conti, V., & Cipriani, A. (2014) · Drug Safety · doi:10.1007/s40264-013-0127-6 · Cited by 78
Factors Associated With Racial Differences in Myocardial Infarction Outcomes
Spertus, J. A., Jones, P. G., Masoudi, F. A., Rumsfeld, J. S., & Krumholz, H. M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-5-200903030-00007 · Cited by 73
Melek, J., & Sakuraba, A. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.08.024 · Cited by 72
Hormone therapies and venous thromboembolism: where are we now?
Vlieg, A. V. H., & Middeldorp, S. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04148.x · Cited by 70
Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women
Canonico, M., Plu‐Bureau, G., O’Sullivan, M. J., Stefanick, M. L., Cochrane, B. B., Scarabin, P., & Manson, J. E. (2013) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31829752e0 · Cited by 71
Self-citationRisk of recurrent venous thromboembolism after a first oestrogen-associated episode
Gal, G. L., Kovacs, M. J., Carrier, M., Do, K., Kahn, S. R., Wells, P., Anderson, D. R., Chagnon, I., Solymoss, S., Crowther, M. A., et al. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-10-0685 · Cited by 68
Metadata
- Authors
- Canonico, M., Plu-Bureau, G., Lowe, G. D. O., & Scarabin, P.-Y.
- Affiliations
- Université Paris-Sud (FR)
- Glasgow Royal Infirmary (GB)
- Corresponding author
- Canonico, Marianne
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2008-05-20
- Volume
- 336
- Issue
- 7655
- Pages
- 1227-1231
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- PMC
- PMC2405857
- OpenAlex
- W2008660261
- Cited by
- 569
- References
- 73
- Citations by year
- 2026: 25 · 2025: 31 · 2024: 20 · 2023: 17 · 2022: 29 · 2021: 30 · 2020: 21 · 2019: 29 · 2018: 27 · 2017: 26 · 2016: 30 · 2015: 28 · 2014: 32 · 2013: 45 · 2012: 35
- FWCI
- 6.50
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- BMJ (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Clinical Neurology › Cerebral Venous Sinus Thrombosis
- Keywords
- hormone replacement therapy, venous thromboembolism, postmenopausal women, oral estrogen, transdermal estrogen, obesity, unopposed estrogen, progestogens, thrombosis risk, treatment duration
- MeSH terms
- Administration, Cutaneous, Administration, Oral, Female, Humans, Risk, Risk Factors, Estrogen Replacement Therapy, Randomized Controlled Trials as Topic, Postmenopause, Venous Thromboembolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
